All Posts By

Smartkarma Daily Briefs

Daily Brief Consumer: Tuhu Car, L’Occitane, Cello World Limited, Japan Tobacco, Oriental Watch, Japfa Comfeed Indonesia, Garrett Motion, Dr Ing hc F Porsche , paragon AG and more

By | Consumer, Daily Briefs

In today’s briefing:

  • HSCI Index Rebalance Preview: Tuhu Car in the Driver’s Seat; Keep Inc in the Running
  • L’Occitane (973 HK):  Sol De Janeiro Growth Taking Off
  • Cello World IPO – Strong past Growth but Has a Number of Related Party Issues
  • Japan Tobacco High Conviction Call: Could Leave 2023 Guidance in the Dust
  • Oriental Watch: Gone Ex-Dividend, Higher Yield, But Sales Softening in The Short-Term
  • Japfa Comfeed – ESG Report – Lucror Analytics
  • GTX: Currency Overshadows Wins
  • Porsche: Q3 Results Confirm Investment Case
  • paragon – A dip in the road ahead


HSCI Index Rebalance Preview: Tuhu Car in the Driver’s Seat; Keep Inc in the Running

By Brian Freitas

  • There were only 14 new listing on the Main Board of the HKEX (388 HK) in the third quarter. Half of the listings were in the last week of September.
  • Of those stocks, only Tuhu Car (9690 HK) and Keep (3650 HK) have a chance of being added to the HSCI in December and then into Southbound Stock Connect.
  • Keep Inc (3650 HK) could be added to Stock Connect in early December while Tuhu Car (9690 HK) will have to wait till April for inclusion to the link.

L’Occitane (973 HK):  Sol De Janeiro Growth Taking Off

By Steve Zhou, CFA

  • L’Occitane (973 HK) reported 2QFY24 operational update last night.  Sales grew 17% yoy on reported currency, and up 25% yoy on constant currency. 
  • The bright spot of the release is the growth of Sol de Janeiro, the Brazilian-inspired premium body care brand, which grew 202% yoy in constant currency in the quarter.
  • Sol de Janeiro has the highest EBIT margin among the 3 major brands of the company, at 24.6% in FY23, suggesting highly profitable growth.

Cello World IPO – Strong past Growth but Has a Number of Related Party Issues

By Sumeet Singh

  • Cello World is looking to raise around US$240m in its upcoming India IPO.
  • Cello World (CW) is an Indian consumer products company. The firm is a leading company in the consumerware market in India.
  • In this note, we look at the company’s past performance.

Japan Tobacco High Conviction Call: Could Leave 2023 Guidance in the Dust

By Oshadhi Kumarasiri

  • Despite conservative 2023 guidance last quarter, Japan Tobacco (2914 JP) is primed to exceed expectations in the 3rd quarter of 2023.
  • Despite no new domestic price hikes, Japan Tobacco’s volume recovery post-hikes is expected to help sustain the revenue and profit growth momentum.
  • New price increases in the Philippines and the UK, coupled with last year’s hikes spillover, are expected to boost Japan Tobacco’s earnings; and the yen’s depreciation amplifies these gains.

Oriental Watch: Gone Ex-Dividend, Higher Yield, But Sales Softening in The Short-Term

By Sameer Taneja

  • Oriental Watch (398 HK) went ex-dividend on the 4th of October. The stock gapped down more than what it paid out and now trades at 6x trailing PE.  
  • Cash at 1.1 bn HKD is greater than 50% of market capitalization, with a high trailing dividend yield of 16.2% and a rich history of paying chunky dividends. 
  • We monitor the sales environment for HK/China, which shows a reasonably good pick-up in HK but lackluster for China.

Japfa Comfeed – ESG Report – Lucror Analytics

By Trung Nguyen

Lucror Analytics’ ESG Scores are based on a 3-tiered scale and are adjusted for Controversies (if applicable).
We view Japfa Comfeed’s ESG as “Adequate”, in line with its Environmental, Social and Governance scores. Controversies are “Immaterial” and Disclosure is “Strong”.


GTX: Currency Overshadows Wins

By Hamed Khorsand

  • GTX continued to showcase its ability to generate free cash flow even though the Euro weakened sequentially. Ahead of the results, we had reduced our estimates citing the stronger Dollar.
  • GTX held an investor day following the quarterly results highlighting how the variable cost structure allows the Company to maintain profitability and generate free cash flow
  • GTX has introduced several new turbochargers for the light vehicle, commercial, and industrial markets. GTX used the investor day to introduce the GT80

Porsche: Q3 Results Confirm Investment Case

By Alexis Dwek

  • Q3 revenues were strong, 4.7% ahead of consensus expectations, and EBIT margin was slightly below at 17% vs. consensus expectations of 17.8%.
  • Key positives are strong revenue growth, EBITDA in Automotive and FCF generation.
  • Post the cautious conference call in Q2, a weaker EBIT margin in Q3 was somewhat expected.

paragon – A dip in the road ahead

By Edison Investment Research

paragon expects extended summer breaks and anticipated year-end shutdowns of customer plants to restrict growth in H223. We have reduced our earnings expectations to reflect the disposal of the battery business and resulting lower growth trajectory, with FY23 and FY24 EPS estimates falling by 9% and 11% respectively. However, the debt reduction continues and the ownership issues have been resolved. Further news on the plan for the Eurobond redemption has yet to be communicated, but should improve the equity outlook and investor sentiment.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ESG: Japfa Comfeed – ESG Report – Lucror Analytics and more

By | Daily Briefs, ESG

In today’s briefing:

  • Japfa Comfeed – ESG Report – Lucror Analytics
  • % of Female Board Members Is a Measure of a Company’s Seriousness About Improving Its Practices


Japfa Comfeed – ESG Report – Lucror Analytics

By Trung Nguyen

Lucror Analytics’ ESG Scores are based on a 3-tiered scale and are adjusted for Controversies (if applicable).
We view Japfa Comfeed’s ESG as “Adequate”, in line with its Environmental, Social and Governance scores. Controversies are “Immaterial” and Disclosure is “Strong”.


% of Female Board Members Is a Measure of a Company’s Seriousness About Improving Its Practices

By Aki Matsumoto

  • The groups with over 30% female board members and 25%-30% have higher percentage of foreign shareholders, suggesting that overseas investor engagement drives raising the ratio and that awareness is high.
  • Groups with 0% female board members include small companies and are distant from overseas investor engagement, but are unlikely to improve practices substantially, given that they have no female executives.
  • The group with over 30% female board members had noticeably higher ROE and Tobin’sQ than those with 25%-30%, which suggests that the high ROE was highly valued by overseas investors.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thematic (Sector/Industry): Ohayo Japan | Cloud Concerns; Cellulose Nanofibers for Sustainability and more

By | Daily Briefs, Thematic (Sector/Industry)

In today’s briefing:

  • Ohayo Japan | Cloud Concerns; Cellulose Nanofibers for Sustainability
  • Top Foundries See Cut in Automotive Industry Wafer Sales, Implications


Ohayo Japan | Cloud Concerns; Cellulose Nanofibers for Sustainability

By Mark Chadwick

  • Overseas: SPX -1.4%, Nasdaq -2.4%; Alphabet -9% on cloud miss; 10-y yield at 4.95%
  • Today: NKY Futs -1% v cash. JPY 150.3; IHI cuts numbers, Honda cancels EV venture with GM
  • JapanX: Yamaha Motor Company’s innovative use of Cellulose Nanofibers (CNF) in watercraft marks a ground breaking step towards sustainability and reduced carbon emissions

Top Foundries See Cut in Automotive Industry Wafer Sales, Implications

By Andrew Lu

  • Both TSMC and UMC saw about 20% cut in automotive industry wafer sales in 3Q23, which was 20% worse than customers’ guidance.
  • Reasons for discrepancies: 1. IDMs cut foundry orders but keep in house utilization higher; 2. Worse than expected US auto factories strike; 3. Rate hike results in worse car sales.
  • We suggest clients to be cautious on the investment of automotive supply chain for the next 3-6 months

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Event-Driven: Cosmo Energy (5021) – Headed to an EGM Showdown for the Poison Pill and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • Cosmo Energy (5021) – Headed to an EGM Showdown for the Poison Pill
  • EOFLOW/Medtronic Tender: Closing Date Extended to 3 January 2024
  • Medtronic’s M&A of Eoflow Timeline Postponed
  • HSCI Index Rebalance Preview: Tuhu Car in the Driver’s Seat; Keep Inc in the Running
  • EOFlow Situation: Latest Disclosure, Market Speculations, & Key Short-Term Focus
  • Azure (AZS AU): SQM The Likely Suitor
  • Hollysys (HOLI US): MBO Proposal and Updates
  • EOFlow/Medtronic: Signs of Life
  • Yuanta/​P-Shares Taiwan Div Plus ETF Rebalance Preview: In-The-Money; Turnover & Trade Remain High
  • SIA Placement Lockup – Time for Another Trim of Its US$7bn Stake


Cosmo Energy (5021) – Headed to an EGM Showdown for the Poison Pill

By Travis Lundy

  • Japanese activist Murakami-san and Cosmo Energy Holdings (5021 JP) have been duking it out for 18 months. He now has 20%. Wants more. Management wants to exercise the poison pill. 
  • Cosmo’s efforts are not completely honest, but Murakami-san’s efforts are clearly designed to benefit Murakami-san over general shareholders, and Cosmo has finally explained the reasons publicly. Read the doc (Japanese).
  • At 1.0x book, lower refining margins vs earlier in the year, and difficulty for Murakami-san to force the issue, one must take more care here than one did 40% ago.

EOFLOW/Medtronic Tender: Closing Date Extended to 3 January 2024

By Arun George

  • The closing date of the Eoflow (294090 KS)/Medtronic Plc (MDT US) transaction has been extended from 25 October 2023 to 3 January 2024. All other terms are unchanged.
  • The bull view is that despite the preliminary injunction and share suspension, Medtronic’s move underscores its commitment to the transaction on current terms.
  • The bear view is that the extension was Medtronic’s best move as it retains option value should Insulet’s lawsuit start floundering in court and KRX reinstate trading in Eoflow shares. 

Medtronic’s M&A of Eoflow Timeline Postponed

By Douglas Kim

  • On 25 October, Eoflow announced that the M&A of Eoflow by Medtronic has been postponed. 
  • The closing date for Eoflow’s stock transfer agreement with Medtronic has now been changed to 3 January 2024. 
  • Although we believe Medtronic will continue to pursue Eoflow, the M&A tender offer price could be lowered to about 26,000 won, which would be nearly 20% higher than current price.

HSCI Index Rebalance Preview: Tuhu Car in the Driver’s Seat; Keep Inc in the Running

By Brian Freitas

  • There were only 14 new listing on the Main Board of the HKEX (388 HK) in the third quarter. Half of the listings were in the last week of September.
  • Of those stocks, only Tuhu Car (9690 HK) and Keep (3650 HK) have a chance of being added to the HSCI in December and then into Southbound Stock Connect.
  • Keep Inc (3650 HK) could be added to Stock Connect in early December while Tuhu Car (9690 HK) will have to wait till April for inclusion to the link.

EOFlow Situation: Latest Disclosure, Market Speculations, & Key Short-Term Focus

By Sanghyun Park

  • We must acknowledge that the acquisition contract has not been withdrawn, signifying that we have averted the worst-case scenario.
  • During the shareholders’ meeting on November 15th, it is crucial for us to pay attention to whether personnel from Medtronic are included in the list of new board candidates.
  • If that’s the case, we can infer that Medtronic intends to go through with this deal, regardless of the litigation issues in the United States.

Azure (AZS AU): SQM The Likely Suitor

By David Blennerhassett

  • Lithium mining play Azure Minerals (AZS AU) went into a trading halt Monday (23 October) “regarding a potential change of control transaction“. That halt has been extended to Friday morning
  • The obvious suitor is Sociedad Quimica y Minera de C (SQM/B CI) with 19.9%, who approached Azure with a $2.31/share Offer in August but was rejected.
  • Mark Creasy, a major shareholder in Azure and also a direct stakeholder in Azure’s flagship mine, is the key. Should a firm Offer unfold, expect a chunky premium. 

Hollysys (HOLI US): MBO Proposal and Updates

By Arun George

  • Hollysys Automation Technologies (HOLI US) update notes a new MBO proposal at US$25 per share, a bidders shortlist in several weeks and an update on the special meeting. 
  • The update suggests several potential bidders and enough shareholders with the required record date to convene the special meeting to appoint independent directors. 
  • The MBO proposal, while potentially a delaying tactic, suggests that the Board are under pressure for a solution and is aiming for a friendly takeover. 

EOFlow/Medtronic: Signs of Life

By David Blennerhassett

  • When EOFlow (294090 KS) was suspended on the 11th October, and ceased global sales, either the Medtronic (MDT US) deal was (largely) toast; or it was a tactical move. 
  • I’m firmly in the latter camp. Insulet‘s lawsuit was expected. And completing the transaction enables the more financially and legally resource-rich MDT to become the party to the litigation.
  • The SPA between Jesse Kim and MDT was expected to complete on 25 October. That was not a hard date. It has now been pushed out to 3 January 2024. 

Yuanta/​P-Shares Taiwan Div Plus ETF Rebalance Preview: In-The-Money; Turnover & Trade Remain High

By Brian Freitas

  • Using data from the close on 25 October, there could be 6 adds and 5 deletes to the Yuanta/​P-Shares Taiwan Dividend Plus ETF in December.
  • There will also be capping and funding flows that will lead to a one-way turnover of 19.5% and a one-way trade of US$1.39bn.
  • A long adds/ short deletes trade is up double digits over the last three weeks and there are a few trade adjustments based on the new rankings.

SIA Placement Lockup – Time for Another Trim of Its US$7bn Stake

By Sumeet Singh

  • Temasek raised around US$300m via its secondary selldown in Singapore Airlines (SIA SP) in Jun 2023. The lockup from that placement will expire soon.
  • Temasek still owns over 50% of SIA and hence, any selldown might not come before SIA reports its 1H23/24 results in mid-Nov 2023.
  • In this note, we talk about the placement lockup dynamics.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: LS Materials IPO Preview and more

By | Daily Briefs, ECM

In today’s briefing:

  • LS Materials IPO Preview
  • Cello World IPO – Strong past Growth but Has a Number of Related Party Issues
  • J&T Global Express IPO Trading – Tepid Demand Despite the Team Effort
  • WuXi XDC Pre-IPO – Thoughts on Valuation – While TAM Is Uncertain, Sales and PAT Are Set to Double


LS Materials IPO Preview

By Douglas Kim

  • LS Materials is getting ready to complete its IPO in Korea in late November. The IPO price range is from 4,400 won to 5,500 won per share. 
  • According to the bankers’ valuation, the expected market cap after the IPO is from 298 billion won to 372 billion won. 
  • LS Materials is one of the largest players globally in the large-size ultracapacitors, which stabilize power supply and are used to replace and supplement primary batteries and lithium-ion batteries.

Cello World IPO – Strong past Growth but Has a Number of Related Party Issues

By Sumeet Singh

  • Cello World is looking to raise around US$240m in its upcoming India IPO.
  • Cello World (CW) is an Indian consumer products company. The firm is a leading company in the consumerware market in India.
  • In this note, we look at the company’s past performance.

J&T Global Express IPO Trading – Tepid Demand Despite the Team Effort

By Sumeet Singh

  • J&T Global Express (1519 HK), a global logistics service provider, raised around US$500m in its Hong Kong IPO.
  • As per Frost & Sullivan (F&S), the firm is the leading express delivery business in Southeast Asia, with a 22.5% market share as per 2022 parcel volume.
  • We have looked at the company’s past performance and valuations in our previous notes. In this note, we talk about the trading dynamics.

WuXi XDC Pre-IPO – Thoughts on Valuation – While TAM Is Uncertain, Sales and PAT Are Set to Double

By Clarence Chu

  • WuXi XDC Cayman Inc (1877628D HK) is looking to raise around US$500m in its upcoming Hong Kong IPO.
  • WuXi XDC Cayman (WXDC) is a CRDMO focused on the global antibody drug conjugates (ADC) and broader bioconjugate market providing integrated and end-to-end services.
  • In our previous notes we looked at the company’s past performance and peer comparison. In this note, we discuss our thoughts on valuation.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Credit: Morning Views Asia: Adani Green Energy and more

By | Credit, Daily Briefs

In today’s briefing:

  • Morning Views Asia: Adani Green Energy, SK Hynix


Morning Views Asia: Adani Green Energy, SK Hynix

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Crypto: Through the Fire – Will the Rubber Meet the Road? and more

By | Crypto, Daily Briefs

In today’s briefing:

  • Through the Fire – Will the Rubber Meet the Road?


Through the Fire – Will the Rubber Meet the Road?

By Delphi Digital

  • Crypto prices are still tracking our expected cycle trend, and the next big test is whether we see another period of consolidation — or if the breakout is finally near.
  • We outline a few notable risks in the near term that may stand in the way of the next crypto uptrend: stagnant liquidity, buyer exhaustion, further tightening in financial conditions
  • We don’t see these risks as long-term trends and view any downside volatility as an opportunity to increase exposure to the best assets at even better entry prices.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Equity Bottom-Up: L’Occitane (973 HK):  Sol De Janeiro Growth Taking Off and more

By | Daily Briefs, Equity Bottom-Up

In today’s briefing:

  • L’Occitane (973 HK):  Sol De Janeiro Growth Taking Off
  • Japan Tobacco High Conviction Call: Could Leave 2023 Guidance in the Dust
  • Appier (4180) | The Ups and Downs
  • UMC (2303.TT; UMC.US): The Early Signs Indicate the End of Inventory Correction.
  • Oriental Watch: Gone Ex-Dividend, Higher Yield, But Sales Softening in The Short-Term
  • Porsche: Q3 Results Confirm Investment Case
  • GTX: Currency Overshadows Wins
  • UOB – Net Profit Down 1.5% YoY, Credit Costs +126% YoY, Citi Costs ~5% of Profit, Expect Worsening
  • Curexo Inc (060280 KS): Strong Growth in Medical Robot Prompts 2023 Guidance Raise
  • GSK Inks Eye-Popping $2B-Plus Pact for Hansoh’s ADC – Is The “New Story” About to Begin?


L’Occitane (973 HK):  Sol De Janeiro Growth Taking Off

By Steve Zhou, CFA

  • L’Occitane (973 HK) reported 2QFY24 operational update last night.  Sales grew 17% yoy on reported currency, and up 25% yoy on constant currency. 
  • The bright spot of the release is the growth of Sol de Janeiro, the Brazilian-inspired premium body care brand, which grew 202% yoy in constant currency in the quarter.
  • Sol de Janeiro has the highest EBIT margin among the 3 major brands of the company, at 24.6% in FY23, suggesting highly profitable growth.

Japan Tobacco High Conviction Call: Could Leave 2023 Guidance in the Dust

By Oshadhi Kumarasiri

  • Despite conservative 2023 guidance last quarter, Japan Tobacco (2914 JP) is primed to exceed expectations in the 3rd quarter of 2023.
  • Despite no new domestic price hikes, Japan Tobacco’s volume recovery post-hikes is expected to help sustain the revenue and profit growth momentum.
  • New price increases in the Philippines and the UK, coupled with last year’s hikes spillover, are expected to boost Japan Tobacco’s earnings; and the yen’s depreciation amplifies these gains.

Appier (4180) | The Ups and Downs

By Mark Chadwick

  • Appier’s stock initially surged 20% following strong Q2 results but later declined 25%, influenced by small-cap stock volatility, AI-induced valuations, and e-commerce sensitivity.
  • The AI company’s competitive position remains strong compared to Braze; the differing stock price performance and valuation suggests significant upside.
  • Appier’s thesis remains intact and we expect the company to benefit from key trends in consumer marketing, first-party data and AI solutions.

UMC (2303.TT; UMC.US): The Early Signs Indicate the End of Inventory Correction.

By Patrick Liao

  • UMC believes that the early signs indicate the end of inventory correction for smartphones and PCs. 
  • The total wafer loading continues to decrease, but pricing for 12″ wafers remains firm. As a result, the average selling price (ASP) continues to increase slightly. 
  • The demand for strength lies in computing, thanks to the LCD controller, codec, Wi-Fi, touch IC controller, and communication applications driven by RFFE and networking IC.

Oriental Watch: Gone Ex-Dividend, Higher Yield, But Sales Softening in The Short-Term

By Sameer Taneja

  • Oriental Watch (398 HK) went ex-dividend on the 4th of October. The stock gapped down more than what it paid out and now trades at 6x trailing PE.  
  • Cash at 1.1 bn HKD is greater than 50% of market capitalization, with a high trailing dividend yield of 16.2% and a rich history of paying chunky dividends. 
  • We monitor the sales environment for HK/China, which shows a reasonably good pick-up in HK but lackluster for China.

Porsche: Q3 Results Confirm Investment Case

By Alexis Dwek

  • Q3 revenues were strong, 4.7% ahead of consensus expectations, and EBIT margin was slightly below at 17% vs. consensus expectations of 17.8%.
  • Key positives are strong revenue growth, EBITDA in Automotive and FCF generation.
  • Post the cautious conference call in Q2, a weaker EBIT margin in Q3 was somewhat expected.

GTX: Currency Overshadows Wins

By Hamed Khorsand

  • GTX continued to showcase its ability to generate free cash flow even though the Euro weakened sequentially. Ahead of the results, we had reduced our estimates citing the stronger Dollar.
  • GTX held an investor day following the quarterly results highlighting how the variable cost structure allows the Company to maintain profitability and generate free cash flow
  • GTX has introduced several new turbochargers for the light vehicle, commercial, and industrial markets. GTX used the investor day to introduce the GT80

UOB – Net Profit Down 1.5% YoY, Credit Costs +126% YoY, Citi Costs ~5% of Profit, Expect Worsening

By Daniel Tabbush

  • UOB (UOB SP) just released their 3Q23 results, with their IR documents attached below. Our interpretation of their numbers is less positive than their own presentation.
  • Credit growth is faltering, with worsening NIM in QoQ, and with what appears to be topping out net interest income. Citi integration costs remain an issue.
  • Underlying credit metrics with worse recoveries and worse new NPAs are not positive, nor is the 126% rise YoY in credit costs in 3Q23.  Will this improve in 4Q23?

Curexo Inc (060280 KS): Strong Growth in Medical Robot Prompts 2023 Guidance Raise

By Tina Banerjee

  • Curexo Inc (060280 KS) has been showing sales growth for five consecutive quarters since Q1 2022, mainly driven by the medical robot business, which accounts for nearly 50% of sales.
  • In 2Q23, Curexo’s medical business sold 29 units and recorded highest quarterly sales of KRW9,744M (up 173% YoY and 15% QoQ), driven by strong demand in domestic and Indian market.
  • Curexo raised 2023 sales guidance to KRW74 billion from KRW70 billion. Medical business is expected to sell 100 units and register revenue of KRW35 billion in 2023.

GSK Inks Eye-Popping $2B-Plus Pact for Hansoh’s ADC – Is The “New Story” About to Begin?

By Xinyao (Criss) Wang

  • The early-stage clinical data of Hansoh’s B7-H4 ADC showed good potential, thus attracting GSK’s attention. This would allow GSK to re-enhance the layout of ADC pipelines after its previous setbacks.
  • However, if future clinical data fail to meet expectation, GSK could return the product to Hansoh. After all, US$85 million upfront is more likely to test the waters for GSK.
  • Hansoh is already one step ahead of Hengrui in terms of internationalization. This short-term catalyst would no doubt help lift share prices, but the logic behind the rebound is shaky.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Macro: China Stimulus Update – Centralization of Debt Still Means MORE Debt! and more

By | Daily Briefs, Macro

In today’s briefing:

  • China Stimulus Update – Centralization of Debt Still Means MORE Debt!
  • CX Daily: China Banks Jump on AI Bandwagon to Cut Costs


China Stimulus Update – Centralization of Debt Still Means MORE Debt!

By Jeroen Blokland

  • The latest wave of China stimulus not only confirms the dire financial state of local governments but also indicates that they have reached the limits of their borrowing capacity.
  • China President Xi’s visit to the PBoC raises the likelihood of new interest rate cuts and cuts in the Required Reserve Ratio for banks.
  • This puts the PBoC in a precarious state. No easing means the property recession continues, while the opposite means it must sell more US dollar assets to prevent yuan depreciation.

CX Daily: China Banks Jump on AI Bandwagon to Cut Costs

By Caixin Global

  • AI / In Depth: China banks jump on AI bandwagon to cut costs Banks in China are turning to artificial intelligence to save on labor costs and improve efficiency, but the transition faces both technical and regulatory hurdles, according to experts in the field.
  • Personnel /: China removes defense minister Li Shangfu, state broadcaster says

  • Diplomacy /: China’s top diplomat to visit Washington


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Most Read: Newcrest Mining, Gs Yuasa Corp, Cosmo Energy Holdings , Eoflow , Tuhu Car, LS Materials, Hollysys Automation Technologies, Medtronic Plc and more

By | Daily Briefs, Most Read

In today’s briefing:

  • Newcrest/Newmont Conclusion Nearing – Flowfront & Gold Price
  • Solactive Global Lithium Index Rebalance: 45% Turnover & US$980m Trade
  • Cosmo Energy (5021) – Headed to an EGM Showdown for the Poison Pill
  • EOFLOW/Medtronic Tender: Closing Date Extended to 3 January 2024
  • HSCI Index Rebalance Preview: Tuhu Car in the Driver’s Seat; Keep Inc in the Running
  • Medtronic’s M&A of Eoflow Timeline Postponed
  • EOFlow Situation: Latest Disclosure, Market Speculations, & Key Short-Term Focus
  • LS Materials IPO Preview
  • Hollysys (HOLI US): MBO Proposal and Updates
  • EOFlow/Medtronic: Signs of Life


Newcrest/Newmont Conclusion Nearing – Flowfront & Gold Price

By Travis Lundy


Solactive Global Lithium Index Rebalance: 45% Turnover & US$980m Trade

By Brian Freitas

  • Solactive has announced the constituent changes for the Global Lithium Index. There are 8 adds and 9 deletes with implementation at the close on 31 October.
  • Estimated one-way turnover is in excess of 22% and will result in a one-way trade of US$490m. There are 11 stocks with estimated passive flows greater than 1x ADV.
  • The index is not very widely tracked and there could be big moves in stocks today and over the next few days – especially where there is multiple days ADV.

Cosmo Energy (5021) – Headed to an EGM Showdown for the Poison Pill

By Travis Lundy

  • Japanese activist Murakami-san and Cosmo Energy Holdings (5021 JP) have been duking it out for 18 months. He now has 20%. Wants more. Management wants to exercise the poison pill. 
  • Cosmo’s efforts are not completely honest, but Murakami-san’s efforts are clearly designed to benefit Murakami-san over general shareholders, and Cosmo has finally explained the reasons publicly. Read the doc (Japanese).
  • At 1.0x book, lower refining margins vs earlier in the year, and difficulty for Murakami-san to force the issue, one must take more care here than one did 40% ago.

EOFLOW/Medtronic Tender: Closing Date Extended to 3 January 2024

By Arun George

  • The closing date of the Eoflow (294090 KS)/Medtronic Plc (MDT US) transaction has been extended from 25 October 2023 to 3 January 2024. All other terms are unchanged.
  • The bull view is that despite the preliminary injunction and share suspension, Medtronic’s move underscores its commitment to the transaction on current terms.
  • The bear view is that the extension was Medtronic’s best move as it retains option value should Insulet’s lawsuit start floundering in court and KRX reinstate trading in Eoflow shares. 

HSCI Index Rebalance Preview: Tuhu Car in the Driver’s Seat; Keep Inc in the Running

By Brian Freitas

  • There were only 14 new listing on the Main Board of the HKEX (388 HK) in the third quarter. Half of the listings were in the last week of September.
  • Of those stocks, only Tuhu Car (9690 HK) and Keep (3650 HK) have a chance of being added to the HSCI in December and then into Southbound Stock Connect.
  • Keep Inc (3650 HK) could be added to Stock Connect in early December while Tuhu Car (9690 HK) will have to wait till April for inclusion to the link.

Medtronic’s M&A of Eoflow Timeline Postponed

By Douglas Kim

  • On 25 October, Eoflow announced that the M&A of Eoflow by Medtronic has been postponed. 
  • The closing date for Eoflow’s stock transfer agreement with Medtronic has now been changed to 3 January 2024. 
  • Although we believe Medtronic will continue to pursue Eoflow, the M&A tender offer price could be lowered to about 26,000 won, which would be nearly 20% higher than current price.

EOFlow Situation: Latest Disclosure, Market Speculations, & Key Short-Term Focus

By Sanghyun Park

  • We must acknowledge that the acquisition contract has not been withdrawn, signifying that we have averted the worst-case scenario.
  • During the shareholders’ meeting on November 15th, it is crucial for us to pay attention to whether personnel from Medtronic are included in the list of new board candidates.
  • If that’s the case, we can infer that Medtronic intends to go through with this deal, regardless of the litigation issues in the United States.

LS Materials IPO Preview

By Douglas Kim

  • LS Materials is getting ready to complete its IPO in Korea in late November. The IPO price range is from 4,400 won to 5,500 won per share. 
  • According to the bankers’ valuation, the expected market cap after the IPO is from 298 billion won to 372 billion won. 
  • LS Materials is one of the largest players globally in the large-size ultracapacitors, which stabilize power supply and are used to replace and supplement primary batteries and lithium-ion batteries.

Hollysys (HOLI US): MBO Proposal and Updates

By Arun George

  • Hollysys Automation Technologies (HOLI US) update notes a new MBO proposal at US$25 per share, a bidders shortlist in several weeks and an update on the special meeting. 
  • The update suggests several potential bidders and enough shareholders with the required record date to convene the special meeting to appoint independent directors. 
  • The MBO proposal, while potentially a delaying tactic, suggests that the Board are under pressure for a solution and is aiming for a friendly takeover. 

EOFlow/Medtronic: Signs of Life

By David Blennerhassett

  • When EOFlow (294090 KS) was suspended on the 11th October, and ceased global sales, either the Medtronic (MDT US) deal was (largely) toast; or it was a tactical move. 
  • I’m firmly in the latter camp. Insulet‘s lawsuit was expected. And completing the transaction enables the more financially and legally resource-rich MDT to become the party to the litigation.
  • The SPA between Jesse Kim and MDT was expected to complete on 25 October. That was not a hard date. It has now been pushed out to 3 January 2024. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars